Lv4
470 积分 2025-04-02 加入
Kinase inhibitors and monoclonal antibodies in oncology: clinical implications
1天前
已完结
hemoradiotherapy and Subsequent Immunochemotherapy as Conversion Therapy in Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma: A Phase II NEXUS-1 Trial
15天前
已完结
Camrelizumab plus SOX chemotherapy as adjuvant therapy for pathological stage III gastric or gastroesophageal junction adenocarcinoma: a prospective, multicenter, single-arm, phase II trial
21天前
已完结
Sintilimab Plus Chemotherapy for Unresectable Gastric or Gastroesophageal Junction Cancer: The ORIENT-16 Randomized Clinical Trial
28天前
已完结
First-Line Nivolumab Plus Chemotherapy for Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: 3-Year Follow-Up of the Phase III CheckMate 649 Trial
29天前
已完结
Claudin 18.2 as a novel therapeutic target
30天前
已完结
FAST: a randomised phase II study of zolbetuximab (IMAB362) plus EOX versus EOX alone for first-line treatment of advanced CLDN18.2-positive gastric and gastro-oesophageal adenocarcinoma
30天前
已完结
Immunotherapy and targeted therapy as first-line treatment for advanced gastric cancer
30天前
已完结
Zolbetuximab in Gastric or Gastroesophageal Junction Adenocarcinoma
30天前
已完结
Gastric cancer
1个月前
已完结
皖公网安备34019202002308
